blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3626253

EP3626253 - STABLE FORMULATIONS OF LINACLOTIDE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.01.2023
Database last updated on 02.09.2024
FormerThe patent has been granted
Status updated on  11.02.2022
FormerGrant of patent is intended
Status updated on  28.06.2021
FormerRequest for examination was made
Status updated on  05.02.2021
FormerThe application has been published
Status updated on  21.02.2020
Most recent event   Tooltip31.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 03.07.2024  [2024/27]
Applicant(s)For all designated states
Ironwood Pharmaceuticals, Inc.
301 Binney Street
Cambridge, MA 02142 / US
For all designated states
Allergan Pharmaceuticals International Limited
Clonshaugh Business & Technology Park
Dublin 17, D17 E400 / IE
[2022/13]
Former [2020/13]For all designated states
Ironwood Pharmaceuticals, Inc.
301 Binney Street
Cambridge, MA 02142 / US
For all designated states
Forest Laboratories Holdings Limited
Victoria Place, 5th Floor
31 Victoria Street
Hamilton / BM
Inventor(s)01 / MO, Yun
260 Middle Neck Road, Apt. 3L
Great Neck, NY 11021 / US
02 / FRETZEN, Angelika
7 Avon Street
Somerville, MA Massachusetts 02143 / US
03 / CALI, Brian
100 Hillside Avenue
Arlington, MA Massachusetts 02476 / US
04 / DEDHIYA, Mahendra
1 Lea Court
Pomona, NY New York 10970 / US
 [2020/13]
Representative(s)Drywood, Rosalind Aerona, et al
Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG / GB
[2022/11]
Former [2020/13]Drywood, Rosalind Aerona, et al
Mathys & Squire LLP The Shard
32 London Bridge Street
London SE1 9SG / GB
Application number, filing date19191344.111.08.2011
[2020/13]
Priority number, dateUS201037280410P11.08.2010         Original published format: US 37280410 P
[2020/13]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP3626253
Date:25.03.2020
Language:EN
[2020/13]
Type: A3 Search report 
No.:EP3626253
Date:29.07.2020
Language:EN
[2020/31]
Type: B1 Patent specification 
No.:EP3626253
Date:16.03.2022
Language:EN
[2022/11]
Type: B8 Corrected title page of specification 
No.:EP3626253
Date:20.04.2022
[2022/16]
Search report(s)(Supplementary) European search report - dispatched on:EP30.06.2020
ClassificationIPC:A61K38/10, A61K9/20, A61K47/18, A61P1/00
[2020/13]
CPC:
A61K38/12 (EP,US); A61K38/10 (EP,US); A61K47/18 (US);
A61K9/1611 (EP,US); A61K9/1641 (EP,US); A61K9/1676 (EP,US);
A61P1/00 (EP); A61P1/04 (EP); A61P1/10 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/10]
Former [2020/13]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA12.08.2019
ME12.08.2019
TitleGerman:STABILE LINACLOTIDFORMULIERUNGEN[2020/13]
English:STABLE FORMULATIONS OF LINACLOTIDE[2020/13]
French:FORMULATIONS STABLES DE LINACLOTIDE[2020/13]
Examination procedure29.01.2021Amendment by applicant (claims and/or description)
29.01.2021Examination requested  [2021/10]
29.01.2021Date on which the examining division has become responsible
29.06.2021Communication of intention to grant the patent
01.12.2021Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
01.02.2022Fee for grant paid
01.02.2022Fee for publishing/printing paid
01.02.2022Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP11745896.8  / EP2603232
Opposition(s)19.12.2022No opposition filed within time limit [2023/08]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
01.02.2022Request for further processing filed
01.02.2022Full payment received (date of receipt of payment)
Request granted
10.02.2022Decision despatched
Fees paidRenewal fee
12.08.2019Renewal fee patent year 03
12.08.2019Renewal fee patent year 04
12.08.2019Renewal fee patent year 05
12.08.2019Renewal fee patent year 06
12.08.2019Renewal fee patent year 07
12.08.2019Renewal fee patent year 08
12.08.2019Renewal fee patent year 09
13.08.2020Renewal fee patent year 10
13.08.2021Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.08.2011
AL16.03.2022
AT16.03.2022
CY16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
MK16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
IE11.08.2022
LU11.08.2022
BE31.08.2022
CH31.08.2022
LI31.08.2022
[2024/27]
Former [2024/21]HU11.08.2011
AL16.03.2022
AT16.03.2022
CY16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
IE11.08.2022
LU11.08.2022
BE31.08.2022
CH31.08.2022
LI31.08.2022
Former [2024/18]HU11.08.2011
AL16.03.2022
AT16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
IE11.08.2022
LU11.08.2022
BE31.08.2022
CH31.08.2022
LI31.08.2022
Former [2023/42]AL16.03.2022
AT16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
IE11.08.2022
LU11.08.2022
BE31.08.2022
CH31.08.2022
LI31.08.2022
Former [2023/33]AL16.03.2022
AT16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
IE11.08.2022
LU11.08.2022
CH31.08.2022
LI31.08.2022
Former [2023/21]AL16.03.2022
AT16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
LU11.08.2022
CH31.08.2022
LI31.08.2022
Former [2023/16]AL16.03.2022
AT16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2023/10]AL16.03.2022
AT16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2023/07]AL16.03.2022
AT16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2023/01]AL16.03.2022
AT16.03.2022
CZ16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2022/51]AT16.03.2022
CZ16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2022/50]AT16.03.2022
CZ16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
PT18.07.2022
Former [2022/49]AT16.03.2022
CZ16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
PT18.07.2022
Former [2022/48]AT16.03.2022
CZ16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
PT18.07.2022
Former [2022/47]AT16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
PT18.07.2022
Former [2022/44]FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
RS16.03.2022
SE16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
Former [2022/39]FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
RS16.03.2022
SE16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
Former [2022/36]HR16.03.2022
LT16.03.2022
LV16.03.2022
RS16.03.2022
SE16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
Former [2022/35]HR16.03.2022
LT16.03.2022
RS16.03.2022
SE16.03.2022
BG16.06.2022
NO16.06.2022
Former [2022/33]LT16.03.2022
NO16.06.2022
Documents cited:Search[A]EP1908482  (CHUGAI PHARMACEUTICAL CO LTD [JP]) [A] 1-4,6-12,14 * abstract *;
 [A]WO2010019266  (IRONWOOD PHARMACEUTICALS INC [US], et al) [A] 1-4,6-12,14 * abstract *;
 [A]  - FUJITA MEGUMI ET AL, "Stabilization by meglumine of an amine compound degraded by formaldehyde in tablets.", INTERNATIONAL JOURNAL OF PHARMACEUTICS 15 FEB 2010 LNKD- PUBMED:19931605, (20100215), vol. 386, no. 1-2, ISSN 1873-3476, pages 195 - 200, XP002662715 [A] 1-4,6-12,14 * abstract *

DOI:   http://dx.doi.org/10.1016/j.ijpharm.2009.11.017
by applicantUS7304036
 US7371727
 US20100372804
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.